{"created":"2023-05-15T15:03:01.334274+00:00","id":85378,"links":{},"metadata":{"_buckets":{"deposit":"76f92a3f-1158-420c-9b70-7fdfad851257"},"_deposit":{"created_by":1,"id":"85378","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"85378"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00085378","sets":["1"]},"author_link":["1036418","1036422","1036424","1036425","1036419","1036423","1036420","1036421"],"item_8_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2022-02","bibliographicIssueDateType":"Issued"},"bibliographicVolumeNumber":"68","bibliographic_titles":[{"bibliographic_title":"Asian Journal of Psychiatry"}]}]},"item_8_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"How patients with pre-existing psychiatric disorders are responding to the COVID-19 pandemic remains unclear, and no comprehensive studies have yet been performed. To elucidate (1) which psychiatric disorders were exacerbated during the initial phase of the COVID-19 pandemic and (2) the contributing factors, we prospectively assessed psychiatric symptoms of 1592 psychiatric outpatients in a single-center study using the Global Assessment of Functioning (GAF) before the state of emergency was declared in Japan and during two months under the state of emergency (study period: April 8 to June 7, 2020). We conducted a chi-squared test for the relationship between psychiatric diagnostic category (ICD-10) and exacerbation. To control for confounders, we conducted a logistic regression analysis using sex, age, diagnostic category, and pre-pandemic GAF score as independent variables. Exacerbation rates of patients with mood disorders (F3) and neurotic disorders (F4) were 4.32% and 5.37%, respectively, and were significantly higher than those for patients with organic disorders (F0) and schizophrenic disorders (F2) (X2 (9, N = 1592) = 27.8, p < .01). Logistic regression analysis revealed that patients with F3 and female patients were significantly more affected than patients with other disorders or male patients, respectively (odds ratio (95% confidence interval) = 2.4 (1.2–4.6), p < .01 for F3; 3.1 (1.5–6.6), p < .01 for females). These findings suggest a need for careful management of patients with mood disorders and female psychiatric patients during a pandemic.","subitem_description_type":"Abstract"}]},"item_8_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"Elsevier"}]},"item_8_relation_13":{"attribute_name":"PubMed番号","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"34974375","subitem_relation_type_select":"PMID"}}]},"item_8_relation_14":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"10.1016/j.ajp.2021.102966","subitem_relation_type_select":"DOI"}}]},"item_8_relation_17":{"attribute_name":"関連サイト","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://www.sciencedirect.com/science/article/pii/S1876201821004226?via%3Dihub","subitem_relation_type_select":"URI"}}]},"item_8_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"1876-2018","subitem_source_identifier_type":"ISSN"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Shin, Kurose"}],"nameIdentifiers":[{"nameIdentifier":"1036418","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Funayamaa, Michitaka"}],"nameIdentifiers":[{"nameIdentifier":"1036419","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Takata, Taketo"}],"nameIdentifiers":[{"nameIdentifier":"1036420","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Shimizu, Yusuke"}],"nameIdentifiers":[{"nameIdentifier":"1036421","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Mimura, Yu"}],"nameIdentifiers":[{"nameIdentifier":"1036422","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Kudo, Shun"}],"nameIdentifiers":[{"nameIdentifier":"1036423","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Ogino, Satoyuki"}],"nameIdentifiers":[{"nameIdentifier":"1036424","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Shin, Kurose","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"1036425","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Symptom changes in patients with pre-existing psychiatric disorders in the initial phase of the COVID-19 pandemic: Vulnerability of female patients and patients with mood disorders","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Symptom changes in patients with pre-existing psychiatric disorders in the initial phase of the COVID-19 pandemic: Vulnerability of female patients and patients with mood disorders"}]},"item_type_id":"8","owner":"1","path":["1"],"pubdate":{"attribute_name":"公開日","attribute_value":"2022-03-14"},"publish_date":"2022-03-14","publish_status":"0","recid":"85378","relation_version_is_last":true,"title":["Symptom changes in patients with pre-existing psychiatric disorders in the initial phase of the COVID-19 pandemic: Vulnerability of female patients and patients with mood disorders"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T17:31:56.933293+00:00"}